External open innovation partner programVaccine or immunological control of heartworm infection (Dirofilaria immitis) in dog
Heartworm infection is a serious and life-threatening disease in dog transmitted by mosquitoes. Prevention is essential as treatment is complicated and risky. Current prevention is based on the use of macrocyclic lactones. However, resistances to these molecules are observed especially in the US. Therefore there is a need for other method of prevention.
We are looking for vaccine or immunological solutions for the prevention of canine heartworm. The candidate project should have in vitro (mandatory) & in vivo (optional) efficacy and safety data. Regarding intellectual property, we are interested in partnerships with exclusive rights for veterinary applications.
All proposals will be assessed by our Research & Development team. Based on the level of interest within the Company research portfolio and strategic fit, we will enter into discussion with selected candidate(s), potentially leading to partnership agreements or collaborations.
Proponents that submit proposals of interest will be contacted within 8 weeks of submission to clarify additional details.
Submit your proposal online (it takes about 20 minutes) in a form and length that is sufficient to provide the substance of the proposal and its innovativeness (short description of data on file). The applicant should also provide information about his or her critical knowledge that is applicable for the project and how that knowledge could be supplemented (i.e., what is additionally required to complete the project).
The Company will not share the information beyond its own staff; your initial proposal should contain only non-confidential information.
If your proposal is selected, the Company is open to complete a Confidentiality Disclosure Agreement (CDA).
Biowebspin pays a lot of attention to the privacy, intellectual property, confidentiality and security of its member data.
The Company is a top 10th Worldwide Animal Health Companies in the research, development, production and marketing of pharmaceutical products and vaccines for companion and farm animals (ruminants, pigs, and poultry).
Present in over 100 countries, the Company has averaged double-digit growth since its creation.
The Company works with an extensive network of business and scientific institutions worldwide to keep up with the latest advances in research and to find the best solutions for today and tomorrow.
Biowebspin is the #1 academia-industry partnering network in Life Sciences.
For academics, Biowebspin is the platform to find industrial partners and funding for their research projects matching R&D programs of more than 500 leading Life Sciences companies and foundations.